Upgrade to SI Premium - Free Trial

Intensity Therapeutics, Inc. (INTS) Reports FY Loss of $1.17

March 13, 2025 4:15 PM

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported FY EPS of ($1.17).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

Categories

Earnings